221 related articles for article (PubMed ID: 12548571)
1. Stromal factors involved in prostate carcinoma metastasis to bone.
Cooper CR; Chay CH; Gendernalik JD; Lee HL; Bhatia J; Taichman RS; McCauley LK; Keller ET; Pienta KJ
Cancer; 2003 Feb; 97(3 Suppl):739-47. PubMed ID: 12548571
[TBL] [Abstract][Full Text] [Related]
2. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
[TBL] [Abstract][Full Text] [Related]
3. The effect of bone-associated growth factors and cytokines on the growth of prostate cancer cells derived from soft tissue versus bone metastases in vitro.
Lee HL; Pienta KJ; Kim WJ; Cooper CR
Int J Oncol; 2003 Apr; 22(4):921-6. PubMed ID: 12632088
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
[TBL] [Abstract][Full Text] [Related]
5. [Role of hepatocyte growth factor in invasion of prostate cancer cell lines through tumor-stromal interaction].
Nishimura K; Takada S; Miura H; Tsujimura A; Kitamura M; Nonomura N; Matsumiya K; Okuyama A
Hinyokika Kiyo; 2000 Oct; 46(10):769-74. PubMed ID: 11215208
[TBL] [Abstract][Full Text] [Related]
6. Preferential adhesion of prostate cancer cells to bone is mediated by binding to bone marrow endothelial cells as compared to extracellular matrix components in vitro.
Cooper CR; McLean L; Walsh M; Taylor J; Hayasaka S; Bhatia J; Pienta KJ
Clin Cancer Res; 2000 Dec; 6(12):4839-47. PubMed ID: 11156243
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through TGFbeta and its receptor, TGFbetaRII.
Barrett JM; Rovedo MA; Tajuddin AM; Jilling T; Macoska JA; MacDonald J; Mangold KA; Kaul KL
Prostate; 2006 May; 66(6):632-50. PubMed ID: 16388503
[TBL] [Abstract][Full Text] [Related]
8. Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro.
Lin DL; Tarnowski CP; Zhang J; Dai J; Rohn E; Patel AH; Morris MD; Keller ET
Prostate; 2001 May; 47(3):212-21. PubMed ID: 11351351
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor (EGF) promotes chemomigration of a human prostate tumor cell line, and EGF immunoreactive proteins are present at sites of metastasis in the stroma of lymph nodes and medullary bone.
Rajan R; Vanderslice R; Kapur S; Lynch J; Thompson R; Djakiew D
Prostate; 1996 Jan; 28(1):1-9. PubMed ID: 8545275
[TBL] [Abstract][Full Text] [Related]
10. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
Ye L; Lewis-Russell JM; Kynaston H; Jiang WG
J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136
[TBL] [Abstract][Full Text] [Related]
11. Bi-directional interactions of prostate cancer cells and bone marrow endothelial cells in three-dimensional culture.
Barrett JM; Mangold KA; Jilling T; Kaul KL
Prostate; 2005 Jun; 64(1):75-82. PubMed ID: 15651029
[TBL] [Abstract][Full Text] [Related]
12. Calcium signals in prostate cancer cells: specific activation by bone-matrix proteins.
Lecrone V; Li W; Devoll RE; Logothetis C; Farach-Carson MC
Cell Calcium; 2000 Jan; 27(1):35-42. PubMed ID: 10726209
[TBL] [Abstract][Full Text] [Related]
13. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
[TBL] [Abstract][Full Text] [Related]
14. Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis.
Rubin J; Chung LW; Fan X; Zhu L; Murphy TC; Nanes MS; Rosen CJ
Prostate; 2004 Jan; 58(1):41-9. PubMed ID: 14673951
[TBL] [Abstract][Full Text] [Related]
15. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
[TBL] [Abstract][Full Text] [Related]
17. The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells.
Song Z; Powell WC; Kasahara N; van Bokhoven A; Miller GJ; Roy-Burman P
Cancer Res; 2000 Dec; 60(23):6730-6. PubMed ID: 11118059
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
19. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
[TBL] [Abstract][Full Text] [Related]
20. Modulation of prostate cancer growth in bone microenvironments.
Edlund M; Sung SY; Chung LW
J Cell Biochem; 2004 Mar; 91(4):686-705. PubMed ID: 14991761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
